WPI 3154 (Modafinil 100 mg)
Pill with imprint WPI 3154 is White, Capsule-shape and has been identified as Modafinil 100 mg. It is supplied by Watson Laboratories, Inc.
Modafinil is used in the treatment of narcolepsy; obstructive sleep apnea/hypopnea syndrome; shift work sleep disorder and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Modafinil 100 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 3154
Modafinil
- Imprint
- WPI 3154
- Strength
- 100 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Watson Laboratories, Inc.
- Inactive Ingredients
-
lactose monohydrate,
corn starch,
crospovidone,
croscarmellose sodium,
silicon dioxide,
magnesium stearate,
magnesium silicate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-3499 (Discontinued) | Watson Pharmaceuticals, Inc. |
| 42291-0599 (Discontinued) | AvKare, Inc. |
| 00904-6423 (Discontinued) | Major Pharmaceuticals |
More about modafinil
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (431)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: CNS stimulants
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.